{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T02:53:31Z","timestamp":1771469611386,"version":"3.50.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T00:00:00Z","timestamp":1484092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T00:00:00Z","timestamp":1484092800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Our previous studied indicated that eukaryotic translation initiation factor 3a (eIF3a) increases the sensitive of platinum-based chemotherapy in lung cancer. MiRNAs play an important role in lung carcinogenesis and drug response. In this study, we aimed to identify potential endogenous miRNAs that inhibit eIF3a expression and determine their influence of this inhibition on cisplatin resistance. Using bioinformatics analysis prediction and confirmation with dual-luciferase reporter assays, we found that miRNA-488 inhibited eIF3a expression by directly binding to the 3\u2019UTR of eIF3a. In addition, the overexpression of miRNA-488 inhibited cell migration and invasion in A549 cells, and also inhibited cell proliferation, cell cycle progression by elevated P27 expression. Compared to the parental cell line, A549\/cisplatin (DDP) resistant cells exhibited a higher level of miRNA-488. Moreover, we found that miRNA-488 was associated with cisplatin resistance in three NSCLC cells (A549, H1299 and SK-MES-1). The mechanism of miRNA-488 induced cisplatin resistance was that miRNA-488 activated nucleotide excision repair (NER) by increasing the expression of Replication Protein A (RPA) 14 and X<jats:italic>eroderma pigmentosum group C<\/jats:italic> (XPC). In conclusion, our results demonstrated that miRNA-488 is a tumor suppressor miRNA that acts by targeting eIF3a. Moreover, miRNA-488 also participates in eIF3a mediated cisplatin resistance in NSCLC cells.<\/jats:p>","DOI":"10.1038\/srep40384","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T10:49:56Z","timestamp":1484131796000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["MiR-488 inhibits proliferation and cisplatin sensibility in non-small-cell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway"],"prefix":"10.1038","volume":"7","author":[{"given":"Chao","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na-Yiyuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji-Ye","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang-Ping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan-Shun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhao-Qian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,11]]},"reference":[{"key":"BFsrep40384_CR1","doi-asserted-by":"crossref","unstructured":"Losanno, T. & Gridelli, C. Safety profiles of first-line therapies for metastatic non-squamous non-small-cell lung cancer. Expert opinion on drug safety, doi: 10.1517\/14740338.2016.1170116 (2016).","DOI":"10.1517\/14740338.2016.1170116"},{"key":"BFsrep40384_CR2","doi-asserted-by":"crossref","unstructured":"Kadara, H., Scheet, P., Wistuba, II & Spira, A. E. Early events in the molecular pathogenesis of lung cancer. Cancer prevention research (Philadelphia, Pa.), doi: 10.1158\/1940-6207.capr-15-0400 (2016).","DOI":"10.1158\/1940-6207.CAPR-15-0400"},{"key":"BFsrep40384_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel, R., Ma, J., Zou, Z. & Jemal, A. Cancer statistics, 2014. CA: a cancer journal for clinicians 64, 9\u201329, doi: 10.3322\/caac.21208 (2014).","journal-title":"CA: a cancer journal for clinicians"},{"key":"BFsrep40384_CR4","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1056\/NEJMra035536","volume":"350","author":"A Spira","year":"2004","unstructured":"Spira, A. & Ettinger, D. S. Multidisciplinary management of lung cancer. The New England journal of medicine 350, 379\u2013392, doi: 10.1056\/NEJMra035536 (2004).","journal-title":"The New England journal of medicine"},{"key":"BFsrep40384_CR5","doi-asserted-by":"crossref","unstructured":"Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer. a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 26, 4617\u20134625, doi: 10.1200\/jco.2008.17.7162 (2008).","DOI":"10.1200\/JCO.2008.17.7162"},{"key":"BFsrep40384_CR6","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.2217\/pgs.12.91","volume":"13","author":"E Giovannetti","year":"2012","unstructured":"Giovannetti, E., Toffalorio, F., De Pas, T. & Peters, G. J. Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape? Pharmacogenomics 13, 1073\u20131086, doi: 10.2217\/pgs.12.91 (2012).","journal-title":"Pharmacogenomics"},{"key":"BFsrep40384_CR7","doi-asserted-by":"publisher","first-page":"2537","DOI":"10.2741\/2865","volume":"13","author":"MP Perron","year":"2008","unstructured":"Perron, M. P. & Provost, P. Protein interactions and complexes in human microRNA biogenesis and function. Frontiers in bioscience: a journal and virtual library 13, 2537\u20132547 (2008).","journal-title":"Frontiers in bioscience: a journal and virtual library"},{"key":"BFsrep40384_CR8","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros, V. The functions of animal microRNAs. Nature 431, 350\u2013355, doi: 10.1038\/nature02871 (2004).","journal-title":"Nature"},{"key":"BFsrep40384_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281\u2013297 (2004).","journal-title":"Cell"},{"key":"BFsrep40384_CR10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.med.59.053006.104707","volume":"60","author":"R Garzon","year":"2009","unstructured":"Garzon, R., Calin, G. A. & Croce, C. M. MicroRNAs in Cancer. Annual review of medicine 60, 167\u2013179, doi: 10.1146\/annurev.med.59.053006.104707 (2009).","journal-title":"Annual review of medicine"},{"key":"BFsrep40384_CR11","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1074\/mcp.M600399-MCP200","volume":"6","author":"E Damoc","year":"2007","unstructured":"Damoc, E. et al. Structural characterization of the human eukaryotic initiation factor 3 protein complex by mass spectrometry. Molecular & cellular proteomics: MCP 6, 1135\u20131146, doi: 10.1074\/mcp.M600399-MCP200 (2007).","journal-title":"Molecular & cellular proteomics: MCP"},{"key":"BFsrep40384_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.critrevonc.2006.03.005","volume":"59","author":"Z Dong","year":"2006","unstructured":"Dong, Z. & Zhang, J. T. Initiation factor eIF3 and regulation of mRNA translation, cell growth, and cancer. Crit Rev Oncol Hematol 59, 169\u2013180, doi: 10.1016\/j.critrevonc.2006.03.005 (2006).","journal-title":"Crit Rev Oncol Hematol"},{"key":"BFsrep40384_CR13","doi-asserted-by":"publisher","first-page":"3790","DOI":"10.1038\/sj.onc.1207465","volume":"23","author":"Z Dong","year":"2004","unstructured":"Dong, Z., Liu, L. H., Han, B., Pincheira, R. & Zhang, J. T. Role of eIF3 p170 in controlling synthesis of ribonucleotide reductase M2 and cell growth. Oncogene 23, 3790\u20133801, doi: 10.1038\/sj.onc.1207465 (2004).","journal-title":"Oncogene"},{"key":"BFsrep40384_CR14","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1111\/j.1432-0436.2007.00165.x","volume":"75","author":"Z Liu","year":"2007","unstructured":"Liu, Z. et al. Role of eIF3a (eIF3 p170) in intestinal cell differentiation and its association with early development. Differentiation; research in biological diversity 75, 652\u2013661, doi: 10.1111\/j.1432-0436.2007.00165.x (2007).","journal-title":"Differentiation; research in biological diversity"},{"key":"BFsrep40384_CR15","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1093\/carcin\/bgt052","volume":"34","author":"JY Yin","year":"2013","unstructured":"Yin, J. Y. et al. Translational regulation of RPA2 via internal ribosomal entry site and by eIF3a. Carcinogenesis 34, 1224\u20131231, doi: 10.1093\/carcin\/bgt052 (2013).","journal-title":"Carcinogenesis"},{"key":"BFsrep40384_CR16","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1016\/j.yexcr.2009.03.009","volume":"315","author":"Z Dong","year":"2009","unstructured":"Dong, Z. et al. Role of eIF3a in regulating cell cycle progression. Experimental cell research 315, 1889\u20131894, doi: 10.1016\/j.yexcr.2009.03.009 (2009).","journal-title":"Experimental cell research"},{"key":"BFsrep40384_CR17","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1054\/bjoc.2001.1828","volume":"84","author":"R Pincheira","year":"2001","unstructured":"Pincheira, R., Chen, Q. & Zhang, J. T. Identification of a 170-kDa protein over-expressed in lung cancers. British journal of cancer 84, 1520\u20131527, doi: 10.1054\/bjoc.2001.1828 (2001).","journal-title":"British journal of cancer"},{"key":"BFsrep40384_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.lungcan.2012.10.005","volume":"79","author":"X Xu","year":"2013","unstructured":"Xu, X. et al. The A\/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients. Lung Cancer 79, 65\u201372, doi: 10.1016\/j.lungcan.2012.10.005 (2013).","journal-title":"Lung Cancer"},{"key":"BFsrep40384_CR19","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1365-2125.2012.04379.x","volume":"75","author":"X Xu","year":"2013","unstructured":"Xu, X. et al. Association between eIF3alpha polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients. British journal of clinical pharmacology 75, 516\u2013523, doi: 10.1111\/j.1365-2125.2012.04379.x (2013).","journal-title":"British journal of clinical pharmacology"},{"key":"BFsrep40384_CR20","doi-asserted-by":"crossref","unstructured":"Pastorkova, Z., Skarda, J. & Andel, J. The role of microRNA in metastatic processes of non-small cell lung carcinoma. A review. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, doi: 10.5507\/bp.2016.021 (2016).","DOI":"10.5507\/bp.2016.021"},{"key":"BFsrep40384_CR21","doi-asserted-by":"crossref","unstructured":"Langsch, S. et al. miR-29b mediates NF-kB signaling in KRAS-induced non-small cell lung cancers. Cancer research, doi: 10.1158\/0008-5472.can-15-2580 (2016).","DOI":"10.1158\/0008-5472.CAN-15-2580"},{"key":"BFsrep40384_CR22","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.2217\/fon.16.21","volume":"12","author":"LP Jiang","year":"2016","unstructured":"Jiang, L. P., Zhu, Z. T. & He, C. Y. Expression of miRNA-26b in the diagnosis and prognosis of patients with non-small-cell lung cancer. Future oncology (London, England) 12, 1105\u20131115, doi: 10.2217\/fon.16.21 (2016).","journal-title":"Future oncology (London, England)"},{"key":"BFsrep40384_CR23","doi-asserted-by":"publisher","first-page":"e96008","DOI":"10.1371\/journal.pone.0096008","volume":"9","author":"J Shen","year":"2014","unstructured":"Shen, J. et al. The prognostic value of altered eIF3a and its association with p27 in non-small cell lung cancers. PloS one 9, e96008, doi: 10.1371\/journal.pone.0096008 (2014).","journal-title":"PloS one"},{"key":"BFsrep40384_CR24","doi-asserted-by":"publisher","first-page":"4600","DOI":"10.1158\/1078-0432.ccr-10-2591","volume":"17","author":"JY Yin","year":"2011","unstructured":"Yin, J. Y. et al. Effect of eIF3a on response of lung cancer patients to platinum-based chemotherapy by regulating DNA repair. Clinical cancer research: an official journal of the American Association for Cancer Research 17, 4600\u20134609, doi: 10.1158\/1078-0432.ccr-10-2591 (2011).","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"BFsrep40384_CR25","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1172\/jci117388","volume":"94","author":"M Dabholkar","year":"1994","unstructured":"Dabholkar, M., Vionnet, J., Bostick-Bruton, F., Yu, J. J. & Reed, E. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy. The Journal of clinical investigation 94, 703\u2013708, doi: 10.1172\/jci117388 (1994).","journal-title":"The Journal of clinical investigation"},{"key":"BFsrep40384_CR26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev.biochem.73.011303.073723","volume":"73","author":"A Sancar","year":"2004","unstructured":"Sancar, A., Lindsey-Boltz, L. A., Unsal-Kacmaz, K. & Linn, S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annual review of biochemistry 73, 39\u201385, doi: 10.1146\/annurev.biochem.73.011303.073723 (2004).","journal-title":"Annual review of biochemistry"},{"key":"BFsrep40384_CR27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/sj.cr.7290375","volume":"14","author":"G Wang","year":"2004","unstructured":"Wang, G., Dombkowski, A., Chuang, L. & Xu, X. X. The involvement of XPC protein in the cisplatin DNA damaging treatment-mediated cellular response. Cell research 14, 303\u2013314, doi: 10.1038\/sj.cr.7290375 (2004).","journal-title":"Cell research"},{"key":"BFsrep40384_CR28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1158\/1535-7163.385.3.4","volume":"3","author":"BJ Andrews","year":"2004","unstructured":"Andrews, B. J. & Turchi, J. J. Development of a high-throughput screen for inhibitors of replication protein A and its role in nucleotide excision repair. Molecular cancer therapeutics 3, 385\u2013391 (2004).","journal-title":"Molecular cancer therapeutics"},{"key":"BFsrep40384_CR29","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1073\/pnas.73.9.3005","volume":"73","author":"R Benne","year":"1976","unstructured":"Benne, R. & Hershey, J. W. Purification and characterization of initiation factor IF-E3 from rabbit reticulocytes. Proceedings of the National Academy of Sciences of the United States of America 73, 3005\u20133009 (1976).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"BFsrep40384_CR30","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1074\/jbc.272.2.1110","volume":"272","author":"N Methot","year":"1997","unstructured":"Methot, N., Rom, E., Olsen, H. & Sonenberg, N. The human homologue of the yeast Prt1 protein is an integral part of the eukaryotic initiation factor 3 complex and interacts with p170. The Journal of biological chemistry 272, 1110\u20131116 (1997).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep40384_CR31","doi-asserted-by":"publisher","first-page":"18573","DOI":"10.1074\/jbc.273.29.18573","volume":"273","author":"K Asano","year":"1998","unstructured":"Asano, K., Phan, L., Anderson, J. & Hinnebusch, A. G. Complex formation by all five homologues of mammalian translation initiation factor 3 subunits from yeast Saccharomyces cerevisiae. The Journal of biological chemistry 273, 18573\u201318585 (1998).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep40384_CR32","doi-asserted-by":"publisher","first-page":"31901","DOI":"10.1074\/jbc.273.48.31901","volume":"273","author":"KL Block","year":"1998","unstructured":"Block, K. L., Vornlocher, H. P. & Hershey, J. W. Characterization of cDNAs encoding the p44 and p35 subunits of human translation initiation factor eIF3. The Journal of biological chemistry 273, 31901\u201331908 (1998).","journal-title":"The Journal of biological chemistry"},{"key":"BFsrep40384_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1128\/mcb.05770-11","volume":"32","author":"TR Xu","year":"2012","unstructured":"Xu, T. R. et al. Eukaryotic translation initiation factor 3, subunit a, regulates the extracellular signal-regulated kinase pathway. Molecular and cellular biology 32, 88\u201395, doi: 10.1128\/mcb.05770-11 (2012).","journal-title":"Molecular and cellular biology"},{"key":"BFsrep40384_CR34","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1038\/onc.2014.419","volume":"34","author":"T Que","year":"2015","unstructured":"Que, T. et al. Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1. Oncogene 34, 4952\u20134963, doi: 10.1038\/onc.2014.419 (2015).","journal-title":"Oncogene"},{"key":"BFsrep40384_CR35","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ccr.2007.12.008","volume":"13","author":"SL Yu","year":"2008","unstructured":"Yu, S. L. et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer cell 13, 48\u201357, doi: 10.1016\/j.ccr.2007.12.008 (2008).","journal-title":"Cancer cell"},{"key":"BFsrep40384_CR36","first-page":"988","volume":"57","author":"F Bachmann","year":"1997","unstructured":"Bachmann, F., Banziger, R. & Burger, M. M. Cloning of a novel protein overexpressed in human mammary carcinoma. Cancer research 57, 988\u2013994 (1997).","journal-title":"Cancer research"},{"key":"BFsrep40384_CR37","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/(SICI)1097-0142(19981001)83:7<1376::AID-CNCR15>3.0.CO;2-1","volume":"83","author":"A Dellas","year":"1998","unstructured":"Dellas, A. et al. Expression of p150 in cervical neoplasia and its potential value in predicting survival. Cancer 83, 1376\u20131383 (1998).","journal-title":"Cancer"},{"key":"BFsrep40384_CR38","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<95::AID-IJC1>3.0.CO;2-N","volume":"84","author":"G Chen","year":"1999","unstructured":"Chen, G. & Burger, M. M. p150 expression and its prognostic value in squamous-cell carcinoma of the esophagus. International journal of cancer. Journal international du cancer 84, 95\u2013100 (1999).","journal-title":"International journal of cancer. Journal international du cancer"},{"key":"BFsrep40384_CR39","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/ijc.25753","volume":"129","author":"K Sikand","year":"2011","unstructured":"Sikand, K., Slaibi, J. E., Singh, R., Slane, S. D. & Shukla, G. C. miR 488* inhibits androgen receptor expression in prostate carcinoma cells. International journal of cancer. Journal international du cancer 129, 810\u2013819, doi: 10.1002\/ijc.25753 (2011).","journal-title":"International journal of cancer. Journal international du cancer"},{"key":"BFsrep40384_CR40","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1158\/0008-5472.can-09-3153","volume":"70","author":"SK Patnaik","year":"2010","unstructured":"Patnaik, S. K., Kannisto, E., Knudsen, S. & Yendamuri, S. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer research 70, 36\u201345, doi: 10.1158\/0008-5472.can-09-3153 (2010).","journal-title":"Cancer research"},{"key":"BFsrep40384_CR41","doi-asserted-by":"crossref","unstructured":"Zhao, Y. et al. miR-488 acts as a tumor suppressor gene in gastric cancer. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine, doi: 10.1007\/s13277-015-4645-y (2016).","DOI":"10.1007\/s13277-015-4645-y"},{"key":"BFsrep40384_CR42","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1423-0127-20-31","volume":"20","author":"J Song","year":"2013","unstructured":"Song, J. et al. MicroRNA-488 regulates zinc transporter SLC39A8\/ZIP8 during pathogenesis of osteoarthritis. Journal of biomedical science 20, 31, doi: 10.1186\/1423-0127-20-31 (2013).","journal-title":"Journal of biomedical science"},{"key":"BFsrep40384_CR43","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/cbi20100204","volume":"35","author":"J Song","year":"2011","unstructured":"Song, J., Kim, D. & Jin, E. J. MicroRNA-488 suppresses cell migration through modulation of the focal adhesion activity during chondrogenic differentiation of chick limb mesenchymal cells. Cell biology international 35, 179\u2013185, doi: 10.1042\/cbi20100204 (2011).","journal-title":"Cell biology international"},{"key":"BFsrep40384_CR44","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1146\/annurev.bi.65.070196.001031","volume":"65","author":"RD Wood","year":"1996","unstructured":"Wood, R. D. DNA repair in eukaryotes. Annual review of biochemistry 65, 135\u2013167, doi: 10.1146\/annurev.bi.65.070196.001031 (1996).","journal-title":"Annual review of biochemistry"},{"key":"BFsrep40384_CR45","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/10409239991209255","volume":"34","author":"C Iftode","year":"1999","unstructured":"Iftode, C., Daniely, Y. & Borowiec, J. A. Replication protein A (RPA): the eukaryotic SSB. Crit Rev Biochem Mol Biol 34, 141\u2013180, doi: 10.1080\/10409239991209255 (1999).","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"BFsrep40384_CR46","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.dnarep.2004.03.020","volume":"3","author":"D Shechter","year":"2004","unstructured":"Shechter, D., Costanzo, V. & Gautier, J. Regulation of DNA replication by ATR: signaling in response to DNA intermediates. DNA repair 3, 901\u2013908, doi: 10.1016\/j.dnarep.2004.03.020 (2004).","journal-title":"DNA repair"},{"key":"BFsrep40384_CR47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/nar\/gkn895","volume":"37","author":"TR Salas","year":"2009","unstructured":"Salas, T. R., Petruseva, I., Lavrik, O. & Saintome, C. Evidence for direct contact between the RPA3 subunit of the human replication protein A and single-stranded DNA. Nucleic acids research 37, 38\u201346, doi: 10.1093\/nar\/gkn895 (2009).","journal-title":"Nucleic acids research"},{"key":"BFsrep40384_CR48","doi-asserted-by":"publisher","first-page":"5293","DOI":"10.1093\/emboj\/cdg489","volume":"22","author":"T Riedl","year":"2003","unstructured":"Riedl, T., Hanaoka, F. & Egly, J. M. The comings and goings of nucleotide excision repair factors on damaged DNA. The EMBO journal 22, 5293\u20135303, doi: 10.1093\/emboj\/cdg489 (2003).","journal-title":"The EMBO journal"},{"key":"BFsrep40384_CR49","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/carcin\/23.2.295","volume":"23","author":"Y Qiao","year":"2002","unstructured":"Qiao, Y. et al. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD\/ERCC2 genotypes. Carcinogenesis 23, 295\u2013299 (2002).","journal-title":"Carcinogenesis"},{"key":"BFsrep40384_CR50","doi-asserted-by":"publisher","first-page":"25441","DOI":"10.18632\/oncotarget.4555","volume":"6","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. eIF3a improve cisplatin sensitivity in ovarian cancer by regulating XPC and p27Kip1 translation. Oncotarget 6, 25441\u201325451, doi: 10.18632\/oncotarget.4555 (2015).","journal-title":"Oncotarget"},{"key":"BFsrep40384_CR51","doi-asserted-by":"publisher","first-page":"261","DOI":"10.5732\/cjc.009.10487","volume":"29","author":"H Yu","year":"2010","unstructured":"Yu, H., Zhang, C. M. & Wu, Y. S. Research progress in cancer stem cells and their drug resistance. Chinese journal of cancer 29, 261\u2013264 (2010).","journal-title":"Chinese journal of cancer"},{"key":"BFsrep40384_CR52","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1126\/science.271.5257.1861","volume":"271","author":"L Hengst","year":"1996","unstructured":"Hengst, L. & Reed, S. I. Translational control of p27Kip1 accumulation during the cell cycle. Science (New York, N.Y.) 271, 1861\u20131864 (1996).","journal-title":"Science (New York, N.Y.)"},{"key":"BFsrep40384_CR53","doi-asserted-by":"publisher","first-page":"4626","DOI":"10.1128\/mcb.00862-06","volume":"27","author":"E Susaki","year":"2007","unstructured":"Susaki, E., Nakayama, K. & Nakayama, K. I. Cyclin D2 translocates p27 out of the nucleus and promotes its degradation at the G0-G1 transition. Molecular and cellular biology 27, 4626\u20134640, doi: 10.1128\/mcb.00862-06 (2007).","journal-title":"Molecular and cellular biology"},{"key":"BFsrep40384_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1101\/gad.1384406","volume":"20","author":"A Besson","year":"2006","unstructured":"Besson, A. et al. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes & development 20, 47\u201364, doi: 10.1101\/gad.1384406 (2006).","journal-title":"Genes & development"},{"key":"BFsrep40384_CR55","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1091\/mbc.E02-12-0784","volume":"14","author":"Z Dong","year":"2003","unstructured":"Dong, Z. & Zhang, J. T. EIF3 p170, a mediator of mimosine effect on protein synthesis and cell cycle progression. Molecular biology of the cell 14, 3942\u20133951, doi: 10.1091\/mbc.E02-12-0784 (2003).","journal-title":"Molecular biology of the cell"}],"updated-by":[{"DOI":"10.1038\/s41598-021-01417-w","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T00:00:00Z","timestamp":1636588800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep40384.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep40384","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep40384.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T00:49:04Z","timestamp":1671842944000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep40384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,11]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,2,3]]}},"alternative-id":["BFsrep40384"],"URL":"https:\/\/doi.org\/10.1038\/srep40384","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,11]]},"assertion":[{"value":"22 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-021-01417-w","URL":"https:\/\/doi.org\/10.1038\/s41598-021-01417-w","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"40384"}}